Bravera Control skin aerosol solution 96mg / g 8ml lidocaine

Aflofarm


£19.99 £30.00




Bravera Control aerosol solution is a product containing lycodain - a substance with local anesthetic effect. A dose of spray applied directly to the penis reduces the penis' sensitivity to touch and prevents premature ejaculation.

Composition of Bravera Control skin spray:

The active substance is lidocaine. 1 g of spray contains 96 mg lidocaine. Each press of the spray pump provides 0.085ml of solution (equivalent to 81.98 mg of aerosol containing 7.87 mg of lidocaine).

The other ingredients are:stearic acid, isopropyl myristate, diethylene glycol
monoethyl ether.

The effect of Braver Control spray on the skin:

Bravera Control is a skin aerosol that contains lidocaine as the active substance. Lidocaine, applied directly to the shaft and acorn of the penis, will induce a local anesthetic effect and thus reduce the penis' sensitivity to touch in order to delay the onset of ejaculation.

Application:
The drug lidocaine is indicated for use before intercourse in case of premature ejaculation 

Contraindications to the use of Bravera Control:

A contraindication to the use of the preparation is allergy to lidocaine or any of the other
ingredients of this medicine (patient or partner / partner). Allergy to other local anesthetic amide drugs, partner's pregnancy, damaged or inflamed skin.

Method of administration for Bravera Control:

Cutaneous use (topically on the shaft and glans penis). The recommended dose is 3 to 7 pump strokes, made to cover the shaft and glans of the penis, 5 to
15 minutes before intercourse. If there is excess medicine remaining on the penis after 5 minutes, remove it before intercourse. The amount and duration of application should be selected depending on individual needs. The lowest effective dose should always be used. There should be an interval of at least 4 hours between consecutive doses. The dose of 22 pump presses should not be exceeded within 24 hours.

Warning!
The drug should not be used for more than 1 month without medical supervision.